Cymabay Therapeutics Inc (NASDAQ:CBAY)
| 3.77 Delayed Data As of Nov 26 |  -0.03 / -0.79%Today’s Change | 3.39 Today|||52-Week Range 7.77 | -34.32% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Depreciation And Amortization | 14.0K | 66.0K | 138.0K | 140.0K | ||
| Operating Expenses | Gross Income | -14.0K | -66.0K | -138.0K | -140.0K | |
| General Expenses | 21.1M | 20.5M | 24.1M | 25.5M | ||
| Research And Development | 17.9M | 16.4M | 18.6M | 21.1M | ||
| Total Operating Expenses | 21.1M | 20.6M | 24.3M | 25.6M | ||
| Non-Operating Expenses | Operating Income | -21.1M | -20.6M | -24.3M | -25.6M | |
| Extraordinary Credit | 1.5M | 0.00 | 0.00 | 0.00 | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -18.6M | -19.4M | -23.1M | -24.0M | |
| Net Income | -18.6M | -19.4M | -23.1M | -24.0M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 59.1M | 59.4M | 61.9M | 68.7M | |
| Shares To Calculate EPS Diluted | 59.4M | 59.4M | 61.9M | 68.7M | ||
| Earnings Per Share | EPS | -$0.34 | -$0.32 | -$0.37 | -$0.35 | |
| EPS Diluted | -$0.34 | -$0.33 | -$0.37 | -$0.35 | ||
